Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
SunBird Bio, Inc.
|
D | 2023-05-12 13:11:45 |
Amount To Be Raised
$23,239,099
Associated Brokers / Dealers
N/A
CIK Number
0001749272
Filed Document
0001567619-23-006053
Exclusions or Exemptions
506b
Accepted Date
2023-05-12 13:11:45
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Glympse Bio, Inc.
|
D | 2018-08-06 16:05:11 |
Amount To Be Raised
$30,087,333
Associated Brokers / Dealers
N/A
CIK Number
0001749272
Filed Document
0001749272-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-08-06 16:05:11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Glympse Bio, Inc.
|
D | 2021-12-17 16:01:12 |
Amount To Be Raised
$17,999,987
Associated Brokers / Dealers
N/A
CIK Number
0001749272
Filed Document
0001749272-21-000003
Exclusions or Exemptions
506b
Accepted Date
2021-12-17 16:01:12
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Glympse Bio, Inc.
|
D | 2020-06-12 15:32:21 |
Amount To Be Raised
$45,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001749272
Filed Document
0001749272-20-000003
Exclusions or Exemptions
506b
Accepted Date
2020-06-12 15:32:21
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Glympse Bio, Inc.
|
D/A | 2021-07-01 13:06:53 |
Amount To Be Raised
$46,699,979
Associated Brokers / Dealers
N/A
CIK Number
0001749272
Filed Document
0001749272-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-07-01 13:06:53
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|